These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21949786)

  • 21. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics.
    Yan GR; Yin XF; Xiao CL; Tan ZL; Xu SH; He QY
    J Proteomics; 2011 Dec; 75(2):695-707. PubMed ID: 21964256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPECHT - single-stage phosphopeptide enrichment and stable-isotope chemical tagging: quantitative phosphoproteomics of insulin action in muscle.
    Kettenbach AN; Sano H; Keller SR; Lienhard GE; Gerber SA
    J Proteomics; 2015 Jan; 114():48-60. PubMed ID: 25463755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway.
    Wu Y; Peng H; Cui M; Whitney NP; Huang Y; Zheng JC
    J Neurochem; 2009 May; 109(4):1157-67. PubMed ID: 19302476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.
    Tan W; Martin D; Gutkind JS
    J Biol Chem; 2006 Dec; 281(51):39542-9. PubMed ID: 17056591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry.
    Parker BL; Yang G; Humphrey SJ; Chaudhuri R; Ma X; Peterman S; James DE
    Sci Signal; 2015 Jun; 8(380):rs6. PubMed ID: 26060331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphoproteomic analysis reveals compensatory effects in the piriform cortex of VX nerve agent exposed rats.
    Nirujogi RS; Wright JD; Manda SS; Zhong J; Na CH; Meyerhoff J; Benton B; Jabbour R; Willis K; Kim MS; Pandey A; Sekowski JW
    Proteomics; 2015 Jan; 15(2-3):487-99. PubMed ID: 25403869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motif-specific sampling of phosphoproteomes.
    Ruse CI; McClatchy DB; Lu B; Cociorva D; Motoyama A; Park SK; Yates JR
    J Proteome Res; 2008 May; 7(5):2140-50. PubMed ID: 18452278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoproteomics: new insights into cellular signaling.
    Mumby M; Brekken D
    Genome Biol; 2005; 6(9):230. PubMed ID: 16168091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel protein functions and signaling mechanisms by genetics and quantitative phosphoproteomics in Caenorhabditis elegans.
    Fredens J; Engholm-Keller K; Møller-Jensen J; Larsen MR; Færgeman NJ
    Methods Mol Biol; 2014; 1188():107-24. PubMed ID: 25059608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway.
    Meijer LA; Zhou H; Chan OY; Altelaar AF; Hennrich ML; Mohammed S; Bos JL; Heck AJ
    Mol Biosyst; 2013 Apr; 9(4):732-49. PubMed ID: 23403867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.
    Wijeratne AB; Manning JR; Schultz Jel J; Greis KD
    J Proteome Res; 2013 Oct; 12(10):4268-79. PubMed ID: 24016359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of conventional quantitative and phospho-proteomics reveals new elements in activated Jurkat T-cell receptor pathway maintenance.
    Jouy F; Müller SA; Wagner J; Otto W; von Bergen M; Tomm JM
    Proteomics; 2015 Jan; 15(1):25-33. PubMed ID: 25348772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Analysis of Phosphotyrosine Signaling by Multiple Reaction Monitoring Mass Spectrometry.
    Payne LS; Huang PH
    Methods Mol Biol; 2017; 1636():263-281. PubMed ID: 28730485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and quantitation of signal molecule-dependent protein phosphorylation.
    Groen A; Thomas L; Lilley K; Marondedze C
    Methods Mol Biol; 2013; 1016():121-37. PubMed ID: 23681576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase,
    Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE
    Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.